Accuray is undergoing a critical operational and organizational transformation to address structural profitability issues, but near-term visibility remains severely clouded. While the company is executing ahead of schedule on its cost-reduction program (achieving $10M of its $12M FY26 target), severe geopolitical disruptions in the Middle East and ongoing macroeconomic headwinds in China have forced management to withdraw its fiscal 2026 guidance. The stock has suffered massive downward revisions from Wall Street, with key analysts downgrading to Neutral/Hold and slashing price targets to reflect declining product revenues and margin compression. A Hold recommendation is warranted until there is clear evidence of top-line stabilization and predictable progress on profitability.